Janice M. Mehnert, an expert in phase I therapeutics and the treatment of skin malignancies, was named associate director for clinical research at NYU Langone Health’s Perlmutter Cancer Center.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
